in recent years , the analysis of sce has been considered to be a highly sensitive and additional ( i.e. , with chromosome aberrations ) end point for measuring mutagenic/carcinogenic potential of various environmental agents and is increasingly being used to detect and differentiate among chromosome fragility human diseases that predispose to neoplasia .
C0012634
diseases
C0027651
neoplasia